Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis
- PMID: 31814102
- DOI: 10.1111/acps.13139
Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis
Abstract
Objective: To compare cost-effectiveness of integrated care with therapeutic assertive community treatment (IC-TACT) versus standard care (SC) in multiple-episode psychosis.
Method: Twelve-month IC-TACT in patients with schizophrenia-spectrum and bipolar I disorders were compared with a historical control group. Primary outcomes were entropy-balanced cost-effectiveness based on mental healthcare costs from a payers' perspective and quality-adjusted life years (QALYs) as a measure of health effects during 12-month follow-up.
Results: At baseline, patients in IC-TACT (n = 214) had significantly higher illness severity and lower functioning than SC (n = 56). Over 12 months, IC-TACT had significantly lower days in inpatient (10.3 ± 20.5 vs. 28.2 ± 44.9; P = 0.005) and day-clinic care (2.6 ± 16.7 vs. 16.4 ± 33.7; P = 0.004) and correspondingly lower costs (€-55 084). Within outpatient care, IC-TACT displayed a higher number of treatment contacts (116.3 ± 45.3 vs. 15.6 ± 6.3) and higher related costs (€+1417). Both resulted in lower total costs in IC-TACT (mean difference = €-13 248 ± 2975, P < 0.001). Adjusted incremental QALYs were significantly higher for IC-TACT versus SC (+0.10 ± 0.37, P = 0.05). The probability of cost-effectiveness of IC-TACT was constantly higher than 99%.
Conclusion: IC-TACT was cost-effective compared with SC. The use of prima facies 'costly' TACT teams is highly recommended to improve outcomes and save total cost for patients with severe psychotic disorders.
Trial registration: ClinicalTrials.gov NCT01888627 NCT01081418.
Keywords: QALY; Schizophrenia; assertive community treatment; bipolar disorder; cost utility; severe mental illness.
© 2019 The Authors. Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.
References
-
- Delespaul PH. Consensus regarding the definition of persons with severe mental illness and the number of such persons in the Netherlands. Tijdschr Psychiatr 2013;55:427-438.
-
- Bagalman E, Napili A. Prevalence of Mental Illness in the United States: Data Sources and Estimates, in Library of Congress. Congressional Research Service. Washington, D.C.: U.L.G.D. Department, Editor. 2015.
-
- Lambert M, Ruppelt F, Siem A-K et al. Comorbidity of chronic somatic diseases in patients with psychotic disorders and their influence on 4-year outcomes of integrated care treatment (ACCESS II study). Schizophr Res 2017;193:377-383.
-
- Conus P, Cotton S, Schimmelmann BG et al. Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis. Soc Psychiatry Psychiatr Epidemiol 2017;52:1089-1099.
-
- Fleischhacker WW, Cetkovich-Bakmas M, De Hert M et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 2008;69:514-519.